aSpeculo
ActiveSummary
aSpeculo has been active since 2021 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €385,649 and a net result of €48,239. Equity is growing by ~58.3% per year across the filed fiscal years. Its solvency ranks better than 62% of 16810 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).
Checked score
Score 2025
Axes · tick = 2024
Profitability58▼-42
Solvency100▲+18
Growth78=
Track record94
Bankruptcy probability, 12 months
0.1%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €25,000 at 30 days acceptable
Liquidity tight (current ratio 1.21 against 0.87 in 2024; short-term debt: 22.2% and cash: 1.2% of total assets), and 25.3% of the assets are financed with debt.
Credit check for your own amount and term
Show the recommended maximum : and see how the verdict changes with amount, term and advance.
Signals
Four signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Human health activities (NACE 86)
about 87% fewer bankruptcies
← fewer bankruptcies
more bankruptcies →
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation dateAge against the risk zone
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
74.7%
Return on assets
9.3%
Age of the figures
9 mo
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 07-07-2026, 24 days ahead of the deadline.
NBB · 5 filingsDeviation from the deadline
2025
24 d early
2024
29 d late
2023
128 d late
2022
61 d late
2021
59 d late
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
This company filed its last 5 accounts on average 51 days after the deadline; the sector median for financial year 2024 is 7 days before the deadline, and 36% of the sector filed late.
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. Usually files around 28 September (4 of the last 5 filed years within 70 days of that day).
Companies Code · seven monthsPosition in the running window
30-09-2026 today31-12-2026 close31-07-2027 deadline
History
Go further with this company
How much credit can you give this customer, and on what term?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark What changed in the latest annual accounts?What changed
Your own company? See how customers, suppliers and banks see it and what to improve first.
Investigating this company? Keep it with today's facts in a case file.
Financials · fiscal year 2025, micro schema
In the rankings
#5 company by equity in Kortenaken, Health and social work sector#8 company by total assets in Kortenaken, Health and social work sector
Equity
€385,649▲ 14.3%
2024 · €337,410
Total assets
€516,433▼ 13.3%
2024 · €595,736
Net result
€48,239▼ 69.7%
2024 · €159,122
Working capital
€24,646
2024 · -€28,280
Trend over the years
In euros
In per cent
Ratio
In euros
No line ticked in this group.
In per cent
No line ticked in this group.
Ratio
No line ticked in this group.
Untick a line to hide it. Point at a year (or use the arrow keys on the chart) for the exact figures; the table below gives them all.Sector: the middle half (P25 to P75) of NACE 86, Human health activities, each year against the same schema; no band under 30 filings. Dashed line: the median. Available for Net result, Equity, Total assets, Working capital, Solvency, Current ratio, Return on assets (ROA).
Every figure with its change against the fiscal year before
favourable
unfavourable
Line20212022202320242025
Operating result€34,577-€18,525▼ 46.4%€202,559▲ 993%€210,993▲ 4.2%€124,338▼ 41.1%
Net result€21,916within the sector's middle half-€606below the sector's middle half▼ 97.2%€152,766above the sector's middle half▲ 25,118%€159,122above the sector's middle half▲ 4.2%€48,239within the sector's middle half▼ 69.7%
Equity€24,916below the sector's middle half-€25,522below the sector's middle half▲ 2.4%€178,288within the sector's middle half▲ 599%€337,410within the sector's middle half▲ 89.3%€385,649above the sector's middle half▲ 14.3%
Total assets€548,960within the sector's middle half-€586,513within the sector's middle half▲ 6.8%€618,994above the sector's middle half▲ 5.5%€595,736within the sector's middle half▼ 3.8%€516,433within the sector's middle half▼ 13.3%
Debt€524,044-€560,992▲ 7.1%€440,706▼ 21.4%€258,326▼ 41.4%€130,784▼ 49.4%
Working capital-€128,525below the sector's middle half--€224,716below the sector's middle half▼ 74.8%-€182,109below the sector's middle half▲ 19.0%-€28,280below the sector's middle half▲ 84.5%€24,646within the sector's middle half
Solvency4.5%below the sector's middle half-4.4%below the sector's middle half▼ 0.2pp28.8%below the sector's middle half▲ 24.5pp56.6%within the sector's middle half▲ 27.8pp74.7%within the sector's middle half▲ 18.0pp
Current ratio0.66below the sector's middle half-0.45below the sector's middle half▼ 0.210.49below the sector's middle half▲ 0.040.87below the sector's middle half▲ 0.381.21within the sector's middle half▲ 0.35
Return on assets (ROA)4.0%below the sector's middle half-0.1%below the sector's middle half▼ 3.9pp24.7%within the sector's middle half▲ 24.6pp26.7%within the sector's middle half▲ 2.0pp9.3%below the sector's middle half▼ 17.4pp
above
within
below
the middle half (P25 to P75) of NACE 86, Human health activities, each year against the same schema; no band under 30 filings.
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result falls in 2025; 2025 is 41% below 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €516,433
Fixed assets
€377,123 ▼ 8.6%
Current assets
€139,311 ▼ 23.9%
Equity and liabilities €516,433
Equity
€385,649 ▲ 14.3%
Debt
€130,784 ▼ 49.4%
Debt's share of the balance-sheet total falls from 43.4% to 25.3%. Equity is higher and debt is lower.
Key figures and ratios
EBITDA
€159,876▼
2024 · €246,489
Cash flow
€83,777▼
2024 · €194,619
Debt to equity
0.34▼
2024 · 0.77
ROE
12.5%▼
2024 · 47.2%
Interest coverage
3.32▼
2024 · 142.49
Debt ≤ 1 year
€114,665▼
2024 · €211,356
Debt > 1 year
€16,120▼
2024 · €46,970
Income taxes
€25,402▼
2024 · €51,341
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Peer companies
Historical observationOf the 6,781 companies that looked in July 2024 the way this one looks now, 0.6% went bankrupt within 24 months and 97% are still going.
- Small
- 5 to 10 years old
- solvency 30% or more
- a profit of 5% of the balance sheet or more
0.6%
went bankrupt
2.7%
stopped otherwise
97%
still going
For this company itself Checked computes a bankruptcy probability of 0.1% over twelve months; the group does not contradict it.
How reliable is this rule?
Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,340 companies of July 2024 its group's bankruptcy share. Expected: 1.6%; actually bankrupt within 24 months: 1.7%.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 1.0% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.
An observation about 6,781 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.
Annual accounts
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Non-recurring operating income76A | - | - | €653 | €1,513 | - | - |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €3,195 | €24,285 | €35,331 | €35,496 | €35,538 | ▲ 0.1% |
| Other operating charges640/8 | €614 | €1,209 | €1,883 | €1,115 | €1,511 | ▲ 35.5% |
| Non-recurring operating charges66A | - | - | - | €1 | - | - |
| Gross operating margin9900 | €38,386 | €44,018 | €239,774 | €247,605 | €161,387 | ▼ 34.8% |
| Operating profit (loss)9901 | €34,577 | €18,525 | €202,559 | €210,993 | €124,338 | ▼ 41.1% |
| Financial income75/76B | €2 | - | €7,610 | €1,200 | €606 | ▼ 49.5% |
| Recurring financial income75 | €2 | - | €7,610 | €1,200 | €606 | ▼ 49.5% |
| Financial charges65/66B | €2,196 | €14,379 | -€9,334 | €1,730 | €51,304 | ▲ 2,866% |
| Recurring financial charges65 | €2,196 | €14,379 | -€9,334 | €1,730 | €48,097 | ▲ 2,680% |
| Non-recurring financial charges66B | - | - | - | - | €3,207 | - |
| Profit (loss) for the period before taxes9903 | €32,383 | €4,145 | €219,504 | €210,464 | €73,640 | ▼ 65.0% |
| Income taxes67/77 | €10,467 | €3,539 | €66,738 | €51,341 | €25,402 | ▼ 50.5% |
| Profit (loss) for the period9904 | €21,916 | €606 | €152,766 | €159,122 | €48,239 | ▼ 69.7% |
| Profit (loss) for the period to be appropriated9905 | €21,916 | €606 | €152,766 | €159,122 | €48,239 | ▼ 69.7% |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Total assets20/58 | €548,960 | €586,513 | €618,994 | €595,736 | €516,433 | ▼ 13.3% |
| Fixed assets21/28 | €298,008 | €402,778 | €444,929 | €412,661 | €377,123 | ▼ 8.6% |
| Tangible fixed assets22/27 | €298,008 | €402,778 | €444,929 | €412,661 | €377,123 | ▼ 8.6% |
| Plant, machinery and equipment23 | - | €3,952 | €2,964 | €1,976 | €988 | ▼ 50.0% |
| Furniture and vehicles24 | €76,964 | €115,618 | €104,950 | €94,282 | €83,614 | ▼ 11.3% |
| Other tangible fixed assets26 | €221,043 | €283,207 | €337,015 | €316,403 | €292,521 | ▼ 7.5% |
| Current assets29/58 | €250,952 | €183,736 | €174,065 | €183,075 | €139,311 | ▼ 23.9% |
| Amounts receivable within one year40/41 | €227,595 | €162,497 | €139,703 | €162,479 | €127,907 | ▼ 21.3% |
| Trade receivables40 | €164,485 | €101,974 | €80,580 | €102,350 | €87,688 | ▼ 14.3% |
| Other amounts receivable41 | €63,110 | €60,523 | €59,123 | €60,129 | €40,219 | ▼ 33.1% |
| Cash at bank and in hand54/58 | €17,216 | €21,239 | €31,961 | €16,996 | €6,294 | ▼ 63.0% |
| Deferred charges and accrued income490/1 | €6,141 | - | €2,400 | €3,600 | €5,109 | ▲ 41.9% |
| Equity and liabilities | ||||||
| Total equity and liabilities10/49 | €548,960 | €586,513 | €618,994 | €595,736 | €516,433 | ▼ 13.3% |
| Equity10/15 | €24,916 | €25,522 | €178,288 | €337,410 | €385,649 | ▲ 14.3% |
| Contributions10/11 | €3,000 | €3,000 | €3,000 | €3,000 | €3,000 | = |
| Reserves13 | €21,916 | €22,522 | €175,288 | €334,410 | €382,649 | ▲ 14.4% |
| Distributable reserves133 | €21,916 | €22,522 | €175,288 | €334,410 | €382,649 | ▲ 14.4% |
| Amounts payable17/49 | €524,044 | €560,992 | €440,706 | €258,326 | €130,784 | ▼ 49.4% |
| Amounts payable after more than one year17 | €144,567 | €139,265 | €84,533 | €46,970 | €16,120 | ▼ 65.7% |
| Financial debts170/4 | €144,567 | €139,265 | €84,533 | €46,970 | €16,120 | ▼ 65.7% |
| Amounts payable within one year42/48 | €379,477 | €408,452 | €356,174 | €211,356 | €114,665 | ▼ 45.7% |
| Current portion of amounts payable after more than one year42 | €22,829 | €34,915 | €47,031 | €87,562 | €56,503 | ▼ 35.5% |
| Trade debts44 | €156,407 | €41,995 | €58,484 | €38,847 | €51,419 | ▲ 32.4% |
| Suppliers440/4 | €156,407 | €41,995 | €58,484 | €38,847 | €51,419 | ▲ 32.4% |
| Taxes, remuneration and social security45 | €8,167 | €15,229 | €75,677 | €81,579 | €6,743 | ▼ 91.7% |
| Taxes450/3 | €8,167 | €15,229 | €75,677 | €81,579 | €6,743 | ▼ 91.7% |
| Other amounts payable47/48 | €192,074 | €316,313 | €174,982 | €3,368 | - | - |
| Accrued charges and deferred income492/3 | - | €13,275 | - | - | - | - |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | €21,916 | €606 | €152,766 | €159,122 | €48,239 | ▼ 69.7% |
| + Depreciation and write-downs630 | €3,195 | €24,285 | €35,331 | €35,496 | €35,538 | ▲ 0.1% |
| Operating cash flow (approximation) | €25,111 | €24,890 | €188,098 | €194,619 | €83,777 | ▼ 57.0% |
| Investment in fixed assets (approximation) | - | -€129,055 | -€77,483 | -€3,228 | €0 | ▲ 100% |
| Change in cash | - | €4,023 | €10,722 | -€14,965 | -€10,702 | ▲ 28.5% |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
07-07
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema
2025
29-08
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema · 29 days late
2024
31-12
Financial
Highest result since 2021net €159,122 ▲4.2%
Operating result €210,993, net result €159,122, both a record.
31-12
Financial
Equity above €200,000Eq €337,410 ▲89.3%
4 profitable years in a row build equity to €337,410.
06-12
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema · 128 days late
2023
31-12
Financial
Equity above €150,000Eq €178,288 ▲599%
3 profitable years in a row build equity to €178,288.
30-09
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema · 61 days late
2022
31-12
Financial
Weakest financial yearnet €606 ▼97.2%
Net result drops to €606, the lowest in the series; recovery starts the following year.
28-09
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema · 59 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 1 act read
About the unread acts
We know of 1 Belgian State Gazette act for this company. It has not been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Directors · office · real estate
Directors
1 act for this company is in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Kortenaken · 1 establishment unit since 2021
Ground area
210 m²
Building footprint
210 m²
Volume, LiDAR
2,517 m³
Parcel 24091B0107/00E000, Flanders · tallest building 17.4 m, ±4 floors. Linked by address, not a title deed.
3
companies at this address
See who is registered here
1 establishment unit
aSpeculo
since 20212.315.687.532
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 24091B0107/00E000 | Flanders | 210 m² | 1 · 210 m² | 17.4 m · 4 fl. |
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
Société chirurgicale Laurence Preud'Homme
BE 0812.721.230
Esneux · Eq €385,693
DOCTEUR WALDEMAR WEISS
BE 0882.130.470
Ukkel · Eq €385,722
P.C. Esthetic
BE 0656.879.149
Ukkel · Eq €385,568
BIEBOUW FRG
BE 1000.072.671
Gent · Eq €386,080
Medi-cygne
BE 0778.682.940
Overijse · Eq €385,197
Of 16,627 companies in sector 86220 we hold annual accounts for 7,988. 6,595 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Identification & contact
Identification
Legal formPrivate limited company
Founded18-03-2021
Fiscal year end31-12
Activities, NACEBEL 2025
86220Specialist medical practice
72109Other research and development on natural sciences
E-invoicing
Reachable via Peppol
Peppol ID
0208:0765379983
Also
9925:BE0765379983
Registered
13-10-2025
If you follow this company, Checked tells you the day it leaves the Peppol register.
Register as of 30 September 2026 · Peppol Directory
Scores and ratios are computed by Checked and are not a credit decision.